CCR7 Antikörper (Elab Fluor®700)
Kurzübersicht für CCR7 Antikörper (Elab Fluor®700) (ABIN7566897)
Target
Alle CCR7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Elab Fluor®700 Anti-Human CD197/CCR7 Antibody[G043H7]
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Each lot of this antibody is quality control tested by flow cytometric analysis. Applications vary, the appropriate dilutions must be determined for individual use.
-
Kommentare
-
Matching Isotype Control: E-AB-F09802M1
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Phosphate buffered solution, pH 7.2, containing 0.09 % stabilizer and 1 % protein protectant.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.
-
Haltbarkeit
- 12 months
-
-
- CCR7 (Chemokine (C-C Motif) Receptor 7 (CCR7))
-
Andere Bezeichnung
- CD197
-
Hintergrund
- EBI1, EVI1,CCR-7,CDw197,CMKBR7,CCR7, also known as CD197, is a chemokine receptor that binds CCL19 and CCL21. CCR7 and its ligands link innate and adaptive immunity by affecting interactions between T cells and dendritic cells and their downstream effect. Naive T cells enter the lymph node through high endothelial venules, which express CCL21. Dendritic cells and macrophages enter the lymph node through afferent lymphatics. The encounter of T cells and dendritic cells in the T cell zone is CCR7-dependent. In addition, during immunological surveillance, B cells recirculate between B-cell-rich compartments (follicles or B cell zones) in secondary lymphoid organs, surveying for antigen. After antigen binding, B cells move to the boundary of B and T zones to interact with T-helper cells, this B cell migration is directed by CCR7 and its ligands. CCR7-positive cancer cell expression has been associated with lymph node metastasis.
-
Gen-ID
- 1236
-
UniProt
- P32248
-
Pathways
- Regulation of Actin Filament Polymerization, Positive Regulation of Immune Effector Process
Target
-